CS logo
small CS logo
Krasnoyarsk State Medical Academy

Krasnoyarsk, Russian Federation
University in Krasnoyarsk
Partizana Zheleznyaka St, 1, Krasnoyarsk, Krasnoyarsk Krai, 660022

About Krasnoyarsk State Medical Academy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Janssen Research & Development, LLC
3
Celgene
2
Eisai Limited
2
Amgen
1
Anthera Pharmaceuticals
1
Bayer
1
Biogen
1
Coherus Biosciences, Inc.
1
Janssen Pharmaceutica N.V., Belgium
1
Total Rows: 10

Clinical Trials at Krasnoyarsk State Medical Academy


During the past decade, Krasnoyarsk State Medical Academy conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100440022222200001100113300Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
2008-08-01
2009-01-09
Terminated
21
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
2008-06-01
Terminated
10
FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
2008-07-01
2010-04-01
Completed
625
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
2010-12-09
2017-08-16
Completed
529
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
2013-08-01
2016-03-01
Completed
419
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
2014-05-01
2016-05-01
Completed
647
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Krasnoyarsk State Medical Academy" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "Eisai Limited" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krasnoyarsk State Medical Academy" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Celgene: 2Celgene: 2Eisai Limited: 2Eisai Limited: 2Amgen: 1Amgen: 1Anthera Pharmaceuticals: 1Anthera Pharmaceuticals: 1Bayer: 1Bayer: 1Biogen: 1Biogen: 1Coherus Biosciences, Inc.: 1Coherus Biosciences, Inc.: 1Janssen PharmaceuticaN.V., Belgium: 1Janssen PharmaceuticaN.V., Belgium: 1

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 1Chugai Pharmaceutical: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1

Clinical Trials Conditions at Krasnoyarsk State Medical Academy


According to Clinical.Site data, the most researched conditions in "Krasnoyarsk State Medical Academy" are "Multiple Sclerosis" (4 trials), "Arthritis, Psoriatic" (3 trials), "Epilepsy" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Krasnoyarsk State Medical Academy" in a lesser frequency.

Clinical Trials Intervention Types at Krasnoyarsk State Medical Academy


Most popular intervention types in "Krasnoyarsk State Medical Academy" are "Drug" (18 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Ocrelizumab" (3 trials), "Fenebrutinib" (2 trials), "Guselkumab" (2 trials) and "Zonisamide" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Krasnoyarsk State Medical Academy


The vast majority of trials in "Krasnoyarsk State Medical Academy" are 17 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Krasnoyarsk State Medical Academy


Currently, there are NaN active trials in "Krasnoyarsk State Medical Academy". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Krasnoyarsk State Medical Academy, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Krasnoyarsk State Medical Academy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Recruiting: 5Recruiting: 5Terminated: 2Terminated: 2Active, not recruiting: 1Active, not recruiting: 1